Intelligent Liabilities And Stockholders Equity from 2010 to 2024
| INBS Stock | USD 2.09 0.20 8.73% |
Liabilities And Stockholders Equity | First Reported 2018-06-30 | Previous Quarter 8.8 M | Current Value 17 M | Quarterly Volatility 6.5 M |
Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.6 K, Interest Expense of 6.4 K or Selling General Administrative of 4 M, as well as many indicators such as Price To Sales Ratio of 29.14, Dividend Yield of 0.0 or PTB Ratio of 8.34. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.
Intelligent | Liabilities And Stockholders Equity |
Latest Intelligent Bio's Liabilities And Stockholders Equity Growth Pattern
Below is the plot of the Liabilities And Stockholders Equity of Intelligent Bio Solutions over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Intelligent Bio's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intelligent Bio's overall financial position and show how it may be relating to other accounts over time.
| Liabilities And Stockholders Equity | 10 Years Trend |
|
Liabilities And Stockholders Equity |
| Timeline |
Intelligent Liabilities And Stockholders Equity Regression Statistics
| Arithmetic Mean | 5,314,097 | |
| Geometric Mean | 2,325,576 | |
| Coefficient Of Variation | 122.38 | |
| Mean Deviation | 5,489,449 | |
| Median | 2,327,950 | |
| Standard Deviation | 6,503,515 | |
| Sample Variance | 42.3T | |
| Range | 19.7M | |
| R-Value | 0.75 | |
| Mean Square Error | 20T | |
| R-Squared | 0.56 | |
| Significance | 0 | |
| Slope | 1,089,217 | |
| Total Sum of Squares | 592.1T |
Intelligent Liabilities And Stockholders Equity History
About Intelligent Bio Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Intelligent Bio income statement, its balance sheet, and the statement of cash flows. Intelligent Bio investors use historical funamental indicators, such as Intelligent Bio's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may use each financial statement separately, they are all related. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Intelligent Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Intelligent Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Intelligent Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Liabilities And Stockholders Equity | 14.2 M | 8.4 M |
Pair Trading with Intelligent Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Intelligent Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intelligent Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Intelligent Stock
| 0.86 | DH | Definitive Healthcare Buyout Trend | PairCorr |
| 0.93 | ABT | Abbott Laboratories Financial Report 18th of July 2024 | PairCorr |
Moving against Intelligent Stock
| 0.82 | BSX | Boston Scientific Corp | PairCorr |
| 0.73 | ELV | Elevance Health Financial Report 17th of July 2024 | PairCorr |
| 0.46 | UNH | UnitedHealth Group Financial Report 12th of July 2024 | PairCorr |
The ability to find closely correlated positions to Intelligent Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intelligent Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intelligent Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intelligent Bio Solutions to buy it.
The correlation of Intelligent Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intelligent Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intelligent Bio Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Intelligent Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.